Literature DB >> 16820306

Platelet-rich plasma stimulates porcine articular chondrocyte proliferation and matrix biosynthesis.

K Akeda1, H S An, M Okuma, M Attawia, K Miyamoto, E J-M A Thonar, M E Lenz, R L Sah, K Masuda.   

Abstract

OBJECTIVE: Platelet-rich plasma (PRP) is a fraction of plasma that contains high levels of multiple growth factors. The purpose of this study was to examine the effects of PRP on cell proliferation and matrix synthesis by porcine chondrocytes cultured in alginate beads, conditions that promote the retention of the chondrocytic phenotype, in order to determine the plausibility of using this plasma-derived material for engineering cartilage.
DESIGN: PRP and platelet-poor plasma (PPP) were prepared from adult porcine blood. Adult porcine chondrocytes were cultured in the presence of 10% PRP, 10% PPP or 10% fetal bovine serum (FBS) for 3 days. Cell proliferation, proteoglycan (PG) and collagen synthesis were quantified, and the structure of newly synthesized PG and collagen was characterized.
RESULTS: Treatment with 10% PRP resulted in a small but significant increase in DNA content (+11%, vs FBS; P<0.01; vs PPP; P<0.001). PG and collagen syntheses by the PRP-treated chondrocytes were markedly higher than those by chondrocytes treated by FBS or PPP (PG; PRP: +115% vs FBS; +151% vs PPP, both P<0.0001, collagen; PRP: +163% vs FBS; +163% vs PPP, both P<0.0001). Biochemical analyses revealed that treatment with PRP growth factors did not markedly affect the types of PGs and collagens produced by porcine chondrocytes, suggesting that the cells remained phenotypically stable in the presence of PRP.
CONCLUSION: PRP isolated from autologous blood may be useful as a source of anabolic growth factors for stimulating chondrocytes to engineer cartilage tissue.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16820306     DOI: 10.1016/j.joca.2006.05.008

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  99 in total

1.  Short- and long-term effects of platelet-rich plasma upon healthy equine joints: Clinical and laboratory aspects.

Authors:  Ana Paula L Moraes; Juliana J Moreira; Patrícia M Brossi; Thaís S L Machado; Yara M Michelacci; Raquel Y A Baccarin
Journal:  Can Vet J       Date:  2015-08       Impact factor: 1.008

2.  Buffered platelet-rich plasma enhances mesenchymal stem cell proliferation and chondrogenic differentiation.

Authors:  Allan Mishra; Padmaja Tummala; Aaron King; Byung Lee; Mark Kraus; Victor Tse; Christopher R Jacobs
Journal:  Tissue Eng Part C Methods       Date:  2009-09       Impact factor: 3.056

3.  Platelet-rich plasma increases proliferation of tendon cells by modulating Stat3 and p27 to up-regulate expression of cyclins and cyclin-dependent kinases.

Authors:  T-Y Yu; J-H S Pang; K P-H Wu; L-P Lin; W-C Tseng; W-C Tsai
Journal:  Cell Prolif       Date:  2015-05-25       Impact factor: 6.831

Review 4.  Platelet-Rich Plasma for the Management of Hip and Knee Osteoarthritis.

Authors:  Kim L Bennell; David J Hunter; Kade L Paterson
Journal:  Curr Rheumatol Rep       Date:  2017-05       Impact factor: 4.592

5.  PRP for Degenerative Cartilage Disease: A Systematic Review of Clinical Studies.

Authors:  Lior Laver; Niv Marom; Lad Dnyanesh; Omer Mei-Dan; João Espregueira-Mendes; Alberto Gobbi
Journal:  Cartilage       Date:  2016-09-01       Impact factor: 4.634

6.  Stimulation of the superficial zone protein and lubrication in the articular cartilage by human platelet-rich plasma.

Authors:  Ryosuke Sakata; Sean M McNary; Kazumasa Miyatake; Cassandra A Lee; James M Van den Bogaerde; Richard A Marder; A Hari Reddi
Journal:  Am J Sports Med       Date:  2015-03-26       Impact factor: 6.202

Review 7.  Controlled release strategies for bone, cartilage, and osteochondral engineering--Part II: challenges on the evolution from single to multiple bioactive factor delivery.

Authors:  Vítor E Santo; Manuela E Gomes; João F Mano; Rui L Reis
Journal:  Tissue Eng Part B Rev       Date:  2013-01-30       Impact factor: 6.389

Review 8.  Clinical Update: Why PRP Should Be Your First Choice for Injection Therapy in Treating Osteoarthritis of the Knee.

Authors:  Corey S Cook; Patrick A Smith
Journal:  Curr Rev Musculoskelet Med       Date:  2018-12

9.  Platelet autologous growth factors decrease the osteochondral regeneration capability of a collagen-hydroxyapatite scaffold in a sheep model.

Authors:  Elizaveta Kon; Giuseppe Filardo; Marco Delcogliano; Milena Fini; Francesca Salamanna; Gianluca Giavaresi; Ivan Martin; Maurilio Marcacci
Journal:  BMC Musculoskelet Disord       Date:  2010-09-27       Impact factor: 2.362

10.  Thrombopoietic-mesenchymal interaction that may facilitate both endochondral ossification and platelet maturation via CCN2.

Authors:  Kumi Sumiyoshi; Satoshi Kubota; Rika A Furuta; Kazuta Yasui; Eriko Aoyama; Harumi Kawaki; Kazumi Kawata; Toshihiro Ohgawara; Takashi Yamashiro; Masaharu Takigawa
Journal:  J Cell Commun Signal       Date:  2009-10-02       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.